InnovAge (NASDAQ:INNV) Shares Gap Up Following Analyst Upgrade

Key Points

• InnovAge shares opened higher after KeyCorp raised its price target from $13 to $14 and maintained an overweight rating; the stock opened at $11.70 versus a prior close of $10.52.
• The company reported strong fiscal fourth-quarter revenue of $261.95 million, above the $238.33 million estimate, and forecast fiscal 2027 revenue of $1.05 billion–$1.085 billion with adjusted EBITDA of $105 million–$115 million.
• Profitability remains a concern: fourth-quarter EPS of $0.06 missed estimates, while InnovAge posted a negative net margin and return on equity. Despite KeyCorp’s bullish view, the broader analyst consensus is “Reduce,” with an average price target of $10.50.

InnovAge Holding Corp. (NASDAQ:INNV - Get Free Report) gapped up prior to trading on Wednesday after KeyCorp raised their price target on the stock from $13.00 to $14.00. The stock had previously closed at $10.52, but opened at $11.70. KeyCorp currently has an overweight rating on the stock. InnovAge shares last traded at $11.4080, with a volume of 186,959 shares traded.

Several other equities analysts have also weighed in on INNV. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of InnovAge in a research report on Thursday, August 13th. Wall Street Zen lowered shares of InnovAge from a "buy" rating to a "hold" rating in a research note on Sunday, May 17th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Reduce" and an average price target of $10.50.

InnovAge News Summary

Here are the key news stories impacting InnovAge this week:

• Positive Sentiment: InnovAge forecast fiscal 2027 revenue of approximately $1.05 billion to $1.085 billion and adjusted EBITDA of $105 million to $115 million. The company also expects census growth of 5% to 7.5%, signaling continued expansion of its senior-care business. Fiscal 2027 guidance
• Positive Sentiment: Fiscal fourth-quarter revenue reached $261.95 million, exceeding the analyst estimate of $238.33 million. The revenue beat suggests solid operating momentum despite profitability challenges. InnovAge quarterly results
• Neutral Sentiment: Management highlighted growth milestones and a stronger operational foundation as it begins a new phase of expansion. Investors will likely focus on whether the company can convert that growth into consistent profitability. InnovAge growth milestones
• Negative Sentiment: InnovAge reported fiscal fourth-quarter EPS of $0.06, below estimates ranging from $0.07 to $0.09. The company also posted a negative net margin and negative return on equity, underscoring ongoing profitability risks. InnovAge EPS miss

Institutional Investors Weigh In On InnovAge

A number of institutional investors have recently bought and sold shares of the business. Legal & General Group Plc acquired a new position in InnovAge in the second quarter worth about $25,000. California State Teachers Retirement System raised its holdings in shares of InnovAge by 207.3% in the 2nd quarter. California State Teachers Retirement System now owns 3,365 shares of the company's stock worth $40,000 after buying an additional 2,270 shares in the last quarter. Invesco Ltd. acquired a new stake in InnovAge in the 4th quarter valued at $57,000. CIBC Asset Management Inc bought a new stake in InnovAge in the fourth quarter valued at $57,000. Finally, Deutsche Bank AG raised its stake in InnovAge by 15.1% during the fourth quarter. Deutsche Bank AG now owns 12,775 shares of the company's stock worth $66,000 after acquiring an additional 1,679 shares in the last quarter. Institutional investors and hedge funds own 12.26% of the company's stock.

InnovAge Price Performance

The company's 50 day moving average price is $11.20 and its 200 day moving average price is $9.32. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.03 and a current ratio of 1.03. The company has a market cap of $1.56 billion, a price-to-earnings ratio of -127.67 and a beta of 0.40.

InnovAge (NASDAQ:INNV - Get Free Report) last issued its quarterly earnings data on Tuesday, September 8th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). InnovAge had a negative net margin of 1.22% and a negative return on equity of 4.73%. The business had revenue of $261.95 million during the quarter, compared to the consensus estimate of $238.33 million.

About InnovAge

InnovAge Holdings, Inc NASDAQ: INNV is a healthcare services company that specializes in caring for seniors through the Program of All-Inclusive Care for the Elderly (PACE). Designed for individuals who are eligible for both Medicare and Medicaid, the PACE model integrates medical care, social services and long-term care—delivered primarily in participants' homes and community-based centers. InnovAge's approach centers on interdisciplinary care teams that coordinate everything from primary and specialty medical services to nutritional counseling and recreational activities.

The company's core offerings include comprehensive in-home assessments, physician and nursing services, physical and occupational therapy, prescription medication management, and transportation to medical appointments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.